Onco
ONCO, Inc. is a privately held, family-owned healthcare software company that builds oncology data management software, including the ONCOLog cancer registry platform and ONCONav patient navigation software, for U.S. hospitals, cancer treatment centers, and multi-facility health systems, with an exclusive AI partnership with Inspirata and a recent cloud platform launch (OWA).
- Company typePrivate
- Founded1983
- HeadquartersAsbury Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Onco does
ONCO, Inc. is a privately held, family-owned healthcare software company founded in 1983 and headquartered in Wall Township, New Jersey, that builds oncology data management software and supporting services for U.S. hospitals, cancer treatment centers, and multi-facility health systems. Its flagship product, ONCOLog, is a cancer registry platform that handles casefinding, abstracting, follow-up, and quality control for CoC, NPCR, and SEER accreditation reporting, and is augmented by three add-on modules: ONCONav for patient navigation, Quality Indicator Manager for quality measure tracking, and Interface Manager for HL7-based EMR data acquisition. The platform runs on a Windows-based client with an MS SQL Server backend, and the company is transitioning to a modern cloud-ready web platform called OWA (ONCO Web Application) launched in 2026.
Underlying technology centers on a patient-centric multi-facility database that eliminates duplicate data entry (reported 75% time savings on shared cases), unlimited user-defined fields, and deep HL7 integration with virtually all major EMR systems as well as a long-standing Varian ARIA interface. ONCO has an exclusive partnership with Inspirata to embed AI-powered casefinding and pre-abstraction (E-Path and E-Path Plus) into the ONCOLog-OWA workflow, with reported 99% clinical validation accuracy and 25-35% operational efficiency gains. The product is SOC 2 Type II certified and fully HIPAA compliant, and is supported by ODS-certified staff with hospital-based experience.
The business generates revenue primarily through quote-based annual enterprise software licensing for ONCOLog and add-on modules, with multi-step demo and consultation sales processes delivered through a direct field sales team (no resellers). A secondary professional services stream (abstracting, consulting, accreditation support) was a meaningful contributor until October 2025, when ONCO divested its cancer registry services division to Savista, effectively refocusing the company on software products. The company serves over 770 hospitals across community programs, NCI-designated cancer centers, and integrated health systems, and is led by Co-CEOs Jim and Heidi Hendrickson, with Dr. Ted Williamson (founder) serving as Medical Director and Brad Kirby (formerly of Sentara Healthcare) as COO.
Onco firmographics
Firmographics- Name
- Onco
- Legal name
- ONCO, Inc.
- Website
- https://oncoinc.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ONCO, Inc. is a privately held, family-owned healthcare software company that builds oncology data management software, including the ONCOLog cancer registry platform and ONCONav patient navigation software, for U.S. hospitals, cancer treatment centers, and multi-facility health systems, with an exclusive AI partnership with Inspirata and a recent cloud platform launch (OWA).
- Ownership category
- akta.pro rank
Onco industry classification
Industry- Product category
- Oncology Data Management Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
Keywords
Where Onco is headquartered
LocationHeadquarters
- HQ city
- Asbury Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Onco business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others
Revenue model
- Software Licensing/Subscription: ONCOLog software licensing with bi-annual updates. Supports various deployment options including standalone, terminal server/Citrix, and network configurations.
- Professional Services: Registry professional services including abstracting, consulting, and accreditation support. Staffed with oncology data experts to help eliminate backlogs and provide short-term or long-term support.
- Software Support Services: Technical and registry support services provided by ODSs (Oncology Data Specialists) with hospital-based experience, including NCRA CE approved quarterly web seminars.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise Software Licensing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Onco product offering
Product offeringCore offering
Onco develops and sells oncology data management software, with ONCOLog as the flagship cancer registry platform providing casefinding, abstracting, follow-up, and quality control. The product suite is complemented by the ONCONav patient navigation application, the cloud-ready ONCO Web Application (OWA), HL7-based Interface Manager, Quality Indicator Manager, and Inspirata AI integration. The company also offers software support and professional abstracting and consulting services to hospitals, cancer centers, and multi-facility health systems.
Product overview
ONCO offers an integrated suite of oncology data management software and services. The core platform is ONCOLog Cancer Registry, a comprehensive cancer registry software providing casefinding, abstracting, follow-up, and quality control. This is augmented by ONCONav for patient navigation, Quality Indicator Manager for quality measures tracking, and Interface Manager for data acquisition automation. The company has introduced OWA (ONCO Web Application) as a modern, cloud-ready platform with integrated AI capabilities through a partnership with Inspirata. Professional services including abstracting, consulting, and software support complement the product portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- ONCOLog: Cancer Registry software serving as the central platform for cancer registry operations, providing casefinding, abstracting, follow-up and quality control functionality.
- ONCONav
- Quality Indicator Manager
- Interface Manager
- OWA (ONCO Web Application)
- E-Path
- E-Path Plus
Products and services
- ONCOLog Cancer Registry Flagship oncology data management platform that serves as the central system for cancer registry operations, providing efficiencies for casefinding, abstracting, follow-up, and quality control with interface manager integration, comprehensive reporting for accreditation and quality measures, and multi-facility functionality for enterprise centralization.
- ONCONav Oncology-specific patient navigation software that helps oncology navigators schedule, track, organize, and report patient interactions, supporting structured assessments, barrier documentation, task management, follow-up tracking, and outcomes reporting across single or multi-facility navigation programs.
- ONCO Web Application (OWA) Modern, cloud-ready web platform built as the next-generation interface for ONCOLog, offering an intuitive interface, unlimited custom fields, multi-facility support, robust analytics tools, and built-in Inspirata AI integration for automated casefinding and data extraction.
- Software Support Technical and registry support services provided by Oncology Data Specialists (ODS, formerly CTRs) with hospital-based experience, including Monday-Friday 8 AM-8 PM ET support, NCRA CE approved quarterly web seminars, and dedicated assistance during the annual Commission on Cancer call-for-data period.
- Professional Services / Abstracting and Consulting Professional services offering providing expert support for cancer program management and registry operations, including backlog elimination, short-term or long-term casefinding, abstracting and follow-up support, and accreditation consulting staffed by oncology data specialists.
Quantifiable outcome
- 25-35% greater operational efficiency across casefinding, abstraction, and follow-up with ONCO + Inspirata integration
- +7 more outcomes
Companies that use Onco
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Onco technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability7 records
Feature8 records
Onco partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered strategic and core.
- MD Anderson Cancer CenterstrategicCollaboration on Computer Aided Coding (CAC) interface development. Worked with MD Anderson to expand interface technology for automated data extraction from pathology reports and clinical documentation.
- Varian Medical SystemscorePartnership established in 2005 provides extensive interface with ARIA Electronic Medical Record system. Allows users to automatically import demographic and disease information from the ARIA system into ONCOLog.
- InspiratacoreExclusive partnership bringing AI-powered automation directly into the ONCOLog-OWA workflow. Inspirata's E-Path provides AI/NLP casefinding and E-Path Plus extracts and pre-populates up to 120 data elements per case. The integration achieves 25-35% greater operational efficiency and is validated at 99% accuracy. Provides single point of support for the integrated solution.
- CodeX/mCode FHIRstrategicCodeX Developer/Implementer partnership focused on mCode FHIR interoperability standards for oncology data exchange. ONCO is working to make registrars' jobs easier through standards-based data interoperability.
Scale indicators11 records
Recent moves6 records
Expansion highlights5 records
Onco competitors and assessment
Company assessmentDirect peers
- ERS Inc. (CRStar): ERS provides CRStar, one of the most widely deployed cancer registry software products in the US. Direct competitor to ONCOLog, serving CoC-accredited hospitals, NCI centers, and state registries with similar casefinding, abstracting, and follow-up functionality.
- C/NET Solutions (CNExT): C/NET Solutions sells CNExT, a cancer registry software product used by hospitals and central registries. Direct competitor to ONCOLog in the same cancer registry point-solution category with overlapping customer profiles.
- Elekta (MOSAIQ): Elekta's MOSAIQ Oncology Information System is a radiation-oncology-focused EMR that includes cancer registry/abstracting workflows. Direct competitor in oncology data management, particularly in radiation oncology and integrated cancer center deployments.
Broad incumbents
- Varian Medical Systems (Siemens Healthineers) — ARIA: Varian's ARIA oncology information system is both a long-standing ONCO integration partner (HL7 interface) and a broader-platform competitor. As part of Siemens Healthineers, Varian bundles EMR, treatment, and registry capabilities into a full oncology suite that competes with ONCOLog for enterprise oncology contracts.
- Epic Systems (Beaker): Epic's Beaker anatomic pathology and oncology modules are embedded in the dominant US hospital EHR. As health systems consolidate on Epic, ONCOLog faces displacement pressure at renewals, making Epic a broad incumbent competitor rather than a point-solution peer.
Emerging players
- Inspirata: Inspirata is ONCO's exclusive AI partner (E-Path, E-Path Plus) and a standalone oncology AI/cancer registry vendor to other customers. A strategic partner that is also a partial competitor in the AI-powered casefinding and pre-abstraction space.
- Flatiron Health: Flatiron (a Roche company) provides oncology-specific EHR, data, and analytics for community oncology practices and life sciences research. Competes with ONCO in oncology data capture and downstream analytics, especially for value-based care and research use cases.
- Tempus: Tempus is an AI-driven precision medicine platform that ingests oncology clinical and molecular data. Adjacent/emerging competitor in oncology data infrastructure, with overlapping buyer personas at NCI centers and large health systems.
Others
- Dolbey: Dolbey provides clinical documentation, computer-aided coding, and dictation solutions, including oncology-specific CAC capabilities that overlap with ONCO's CAC interface work. Adjacent vendor in the cancer data workflow rather than a direct registry competitor.
- 3M Health Information Systems (Solventum): 3M (now Solventum) provides health data management, coding, and classification tools widely used in US healthcare. Adjacent in the health data workflow — not a direct registry competitor, but a relevant ecosystem player in oncology data capture and reporting.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Onco compliance and trust
Trust signalCompliance2 records
Onco financial estimates
Financial estimateRevenue estimate
Valuation estimate
Onco leadership team
Management profileNumber of profiles
Profiles5 records
Onco funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Onco M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Onco
What does Onco do?
Onco develops and sells oncology data management software, with ONCOLog as the flagship cancer registry platform providing casefinding, abstracting, follow-up, and quality control. The product suite is complemented by the ONCONav patient navigation application, the cloud-ready ONCO Web Application (OWA), HL7-based Interface Manager, Quality Indicator Manager, and Inspirata AI integration. The company also offers software support and professional abstracting and consulting services to hospitals, cancer centers, and multi-facility health systems.
Is Onco a public or private company?
Onco is a private company. It is classified as family owned and is currently operating.
When was Onco founded?
Onco was founded in 1983. It employs 11 to 50 people.
Where is Onco based?
Onco is headquartered in Asbury Park, United States, in the North America region.
How does Onco make money?
Three revenue lines are on record. Software Licensing/Subscription is the primary driver. The others are professional Services and software Support Services.
Who are Onco's main competitors?
Direct peers on record are ERS Inc. (CRStar), C/NET Solutions (CNExT) and Elekta (MOSAIQ). Broad incumbents are Varian Medical Systems (Siemens Healthineers) — ARIA and Epic Systems (Beaker). Emerging players are Inspirata, Flatiron Health and Tempus. Others are Dolbey and 3M Health Information Systems (Solventum).
Does Onco have an API?
No public API is recorded for Onco.
What industry is Onco in?
Onco's product category is Oncology Data Management Software. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support. Its NAICS code is 5132 and its SIC code is 7372.